Newly-appointed Clinical Cell Culture chief executive Bob Atwill believes the company’s more focused sales and marketing approach will ultimately reap benefits for long-suffering shareholders.
04/07/2006 - 22:00
Atwill narrows focus at C3
04/07/2006 - 22:00